Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 15;23(1):596.
doi: 10.1186/s12888-023-05078-z.

Study on the daily dose and serum concentration of clozapine in psychiatric patients and possible influencing factors of serum concentration

Affiliations

Study on the daily dose and serum concentration of clozapine in psychiatric patients and possible influencing factors of serum concentration

Taixiu Liu et al. BMC Psychiatry. .

Abstract

Background: Clozapine is the most effective drug for treatment-resistant schizophrenia, and the dosage and concentration of clozapine in the treatment of mental illness vary greatly in different populations and are affected by many factors.

Methods: The serum clozapine concentration of 3734 psychiatric patients was detected, and data on daily dose, sex, age and other medical records were collected for statistical analysis.

Results: The mean daily dose, mean serum concentration and mean C/D (concentration/dose) ratio of clozapine were 191.02 ± 113.47 mg/day, 326.15 ± 235.66 ng/mL and 1.94 ± 1.25 ng/mL per mg/day, respectively. There was difference in daily dose between sexes, and females had higher daily dose (p <0.01), higher serum clozapine concentrations (p < 0.01) and higher C/D ratios (p < 0.01). There were significant differences in daily dose (p < 0.001), serum drug concentration (p < 0.001) and C/D ratio (p < 0.001) among different age groups. The daily dose decreased with age (p for trend < 0.001), and the C/D ratio increased with age (p for trend < 0.001). Inpatients and outpatients had no difference in daily dose, but inpatients had higher serum concentration (p < 0.001) and C/D ratio (p < 0.001). There was no difference in daily dose among different occupations, but there were significant differences in serum concentration (p < 0.001) and C/D ratio (p < 0.001), and unemployed patients may have higher serum concentration and C/D ratio. Duration of disease, comorbidity, marital status, and psychotic type may influence the daily dose and serum concentration.

Conclusions: The effective daily dose and serum concentration of clozapine in the study area may be lower than recommended levels, and women have higher serum concentrations and slower metabolic rates. With increasing age, the daily dose decreases, and the metabolic rate slows. Inpatient status and occupation of patients may influence the serum concentration and metabolic rate of clozapine.

Keywords: Clozapine; Daily dose; Serum concentration; Therapeutic drug monitoring (TDM).

PubMed Disclaimer

Conflict of interest statement

Not applicable.

Figures

Fig. 1
Fig. 1
Relationship between the daily dose of clozapine and serum concentration. The linear regression equation of clozapine daily dose and concentration was Y = 122.793 + 1.065*x, R = 0.513, p < 0.001
Fig. 2
Fig. 2
a Relationship between daily dose of clozapine and age groups. With increasing age, the daily dose of clozapine tended to decrease. b1 Relationship between clozapine serum concentrations and age groups. Although there were significant differences in the serum concentrations of clozapine among age groups, there was no significant trend in the daily dose of clozapine with age. b2 Relationship between clozapine serum concentration and age groups.When the subjects were divided into two age groups, 10-44 years old and 45-75 years old, the serum concentration of clozapine was significantly different between the two groups (P <0.01), and the serum concentration of clozapine in the 45-75 years old group was higher than that in the 10-44 years old group. c Relationship between the C/D ratio and age group. With increasing age, the C/D ratio tended to increase. With increasing age, the daily dose of clozapine tended to decrease

Similar articles

Cited by

References

    1. Fitton A, Heel RC. Clozapine. A review of its pharmacological properties, and therapeutic use in schizophrenia. Drugs. 1990;40(5):722–47. - PubMed
    1. Khokhar JY, Henricks AM, Sullivan EDK, Green AI. Unique Effects of Clozapine: a pharmacological perspective. Adv Pharmacol (San Diego Calif) 2018;82:137–62. - PMC - PubMed
    1. Kapczinski F, Pfaffenseller B, Dursun SM, de Azevedo Cardoso T. Clozapine for bipolar disorder: what do we know thus far and what next? Bipolar Disord. 2021;23(2):115–6. - PubMed
    1. Tan MSA, Honarparvar F, Falconer JR, Parekh HS, Pandey P, Siskind DJ. A systematic review and meta-analysis of the association between clozapine and norclozapine serum levels and peripheral adverse drug reactions. Psychopharmacology. 2021;238(3):615–37. - PubMed
    1. Yuen JWY, Kim DD, Procyshyn RM, Panenka WJ, Honer WG, Barr AM. A focused review of the metabolic Side-Effects of Clozapine. Front Endocrinol. 2021;12:609240. - PMC - PubMed